INFI News and Press, Infinity Pharmaceuticals Inc. From 03/25/20

Infinity Pharmaceuticals, Inc . (NASDAQ: INFI) announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for IPI-549 in combination with nivolumab (Opdivo ® ) for the treatment of advanced urothelial cancer. Infinity is currently enrolling patie...

Infinity Pharmaceuticals, Inc . (NASDAQ: INFI) announced today the appointment of Richard Gaynor, M.D. to its Board of Directors, effective March 16, 2020. “We are thrilled to have Dr. Gaynor join the board as we advance IPI-549 to important data readouts,” said Adelene Per...

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Tuesday, March 3, 2020 at 4:30 p.m. ET to review its fourth quarter and full year 2019 financial results and provide an update on the company. A live webcast of the conference call can be accessed in the Invest...

Shares of tiny oncology player Infinity Pharmaceuticals ( INFI ) have lost over 30% of their value since my June 2018 update highlighted intriguing signs of clinical activity for IPI-549, combined with nivolumab in indications not usually responsive to anti-PD-1 therapy. I also noted that we...

Gainers : CSS Industries (NYSE: CSS ) +99% . More news on: CSS Industries, Inc., NanoViricides, Inc., Novavax, Inc., Stocks on the move, , Read more ...

The following slide deck was published by Infinity Pharmaceuticals, Inc. in conjunction with this Read more ...

- Recent Non-Dilutive Financing Extends Cash Runway into 2H 2021 and Fully Funds All Ongoing IPI-549 Clinical Trials Through Key Data Readouts - - MARIO-275 Global, Randomized, Controlled Phase 2 Study in Urothelial Cancer Enrollment Completion Expected in 2020 with Data Expected in M...

Penny stocks are some of the most unique in the market. The biggest reason has to do with the ability to move unassociated with the direction of the stock market. Now, this isn’t always the case. But there’s a good chance that even if the broad stock market is tanking, there are ...

Applied Genetic Technologies (NASDAQ: AGTC ) +53%  on positive XLRP data . More news on: Applied Genetic Technologies Corporation, VBI Vaccines Inc., The Peck Company Holdings, Inc., Stocks on the move, Read more ...

-- Fully funds all ongoing IPI-549 clinical trials through key data readouts -- -- Non-dilutive financing extends cash runway into 2H 2021 -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) (“Infinity”) today announced a $20 million non-dilutive asset-backed financing ...